Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 45.28
+0.70 (1.57%)
May 25, 2026, 5:35 PM CET
Redcare Pharmacy NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,073 | 2,941 | 2,371 | 1,799 | 1,204 | 1,060 | |
Revenue Growth (YoY) | 21.58% | 24.06% | 31.79% | 49.35% | 13.58% | 9.53% |
Cost of Revenue | 2,399 | 2,278 | 1,825 | 1,358 | 872.57 | 793.53 |
Gross Profit | 673.8 | 663.1 | 545.8 | 440.38 | 331.79 | 266.8 |
Selling, General & Admin | 689.2 | 683.7 | 585.1 | 444.49 | 379.17 | 299.21 |
Other Operating Expenses | -0.3 | -0.5 | -0.3 | -0.32 | -0.15 | -0.16 |
Operating Expenses | 688.9 | 683.2 | 584.8 | 444.18 | 379.02 | 299.05 |
Operating Income | -15.1 | -20.1 | -39 | -3.79 | -47.23 | -32.25 |
Interest Expense | -22.5 | -19.9 | -7.8 | -8 | -8.5 | -8.57 |
Interest & Investment Income | 3.6 | 4.4 | 6.4 | 4.61 | - | - |
Earnings From Equity Investments | 0.8 | 0.4 | 0.4 | 0.23 | 0.34 | -0.43 |
Currency Exchange Gain (Loss) | 0.4 | 0.4 | 0.5 | 0.28 | 1.76 | 1.49 |
Other Non Operating Income (Expenses) | -11.4 | -11.3 | -8.4 | -7.02 | -6.97 | -4.53 |
EBT Excluding Unusual Items | -44.2 | -46.1 | -47.9 | -13.7 | -60.6 | -44.28 |
Merger & Restructuring Charges | -1.9 | -1.9 | - | - | -0.32 | - |
Impairment of Goodwill | -1.3 | -1.3 | - | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | -1.58 | -0.16 |
Asset Writedown | -5.2 | -5.2 | - | - | - | - |
Other Unusual Items | 7.3 | 6.8 | - | -0.65 | -21.62 | -33.45 |
Pretax Income | -45.3 | -47.7 | -47.9 | -14.35 | -84.12 | -77.88 |
Income Tax Expense | -6.5 | -8.3 | -1.5 | -2.74 | -6.47 | -3.7 |
Earnings From Continuing Operations | -38.8 | -39.4 | -46.4 | -11.61 | -77.65 | -74.19 |
Minority Interest in Earnings | 1.4 | 1.7 | 0.9 | -0.44 | - | - |
Net Income | -37.4 | -37.7 | -45.5 | -12.04 | -77.65 | -74.19 |
Net Income to Common | -37.4 | -37.7 | -45.5 | -12.04 | -77.65 | -74.19 |
Shares Outstanding (Basic) | - | 20 | 20 | 19 | 18 | 18 |
Shares Outstanding (Diluted) | - | 20 | 20 | 19 | 18 | 18 |
Shares Change (YoY) | - | 0.27% | 4.24% | 6.97% | 0.57% | 24.37% |
EPS (Basic) | - | -1.87 | -2.27 | -0.63 | -4.32 | -4.15 |
EPS (Diluted) | - | -1.87 | -2.27 | -0.63 | -4.32 | -4.15 |
Free Cash Flow | -63 | -48.3 | 13.4 | 55.02 | -42.68 | -2.18 |
Free Cash Flow Per Share | - | -2.40 | 0.67 | 2.86 | -2.37 | -0.12 |
Gross Margin | 21.93% | 22.55% | 23.02% | 24.48% | 27.55% | 25.16% |
Operating Margin | -0.49% | -0.68% | -1.65% | -0.21% | -3.92% | -3.04% |
Profit Margin | -1.22% | -1.28% | -1.92% | -0.67% | -6.45% | -7.00% |
Free Cash Flow Margin | -2.05% | -1.64% | 0.56% | 3.06% | -3.54% | -0.21% |
EBITDA | 7.2 | 2 | -17 | 14.47 | -34 | -21.6 |
EBITDA Margin | 0.23% | 0.07% | -0.72% | 0.80% | -2.82% | -2.04% |
D&A For EBITDA | 22.3 | 22.1 | 22 | 18.27 | 13.23 | 10.65 |
EBIT | -15.1 | -20.1 | -39 | -3.79 | -47.23 | -32.25 |
EBIT Margin | -0.49% | -0.68% | -1.65% | -0.21% | -3.92% | -3.04% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.